We are live on ! Find out more
BIO.B icon

Bio-Rad Laboratories Class B
BIO.B

4 hedge funds and large institutions have $835K invested in Bio-Rad Laboratories Class B in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more capital invested

Capital invested by funds: $797K → $835K (+$38K)

0% more ownership

Funds ownership: 0.14%0.14% (+0%)

20% less funds holding

Funds holding: 54 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
U
UBS
Switzerland
+$20.6K
2
Barclays
Barclays
United Kingdom
+$2.94K
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
$771K
U
2
UBS
Switzerland
$48K +$20.6K +175 +74%
Barclays
3
Barclays
United Kingdom
$10K +$2.94K +25 +39%
Invesco
4
Invesco
Georgia
$6K
California Public Employees Retirement System
5
California Public Employees Retirement System
California
-$20K -181 Closed

BIO.B Hedge Fund Activity: Q3 2013 in Review

4 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class B (BIO.B) for Q3 2013, worth a combined $835K — up 4.8% from $797K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BIO.B and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was UBS, adding an estimated $20.6K. The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $20K sold.

  • 4 institutional investors held Bio-Rad Laboratories Class B (BIO.B) as of Q3 2013, down from 5 in Q2 2013.
  • Funds reported $835K of Bio-Rad Laboratories Class B stock for Q3 2013, up 4.8% quarter-over-quarter.
  • 0 funds opened new Bio-Rad Laboratories Class B positions in Q3 2013 and 1 closed out, a net change of -1 holder.
  • The largest Bio-Rad Laboratories Class B buyer in Q3 2013 was UBS, an estimated $20.6K added.
  • The largest Bio-Rad Laboratories Class B seller in Q3 2013 was California Public Employees Retirement System, an estimated $20K sold.

Based on aggregated 13F filings for Q3 2013.